Hepregen News
Most Popular Hepregen Story
Selecta Biosciences raises $15.1 in Series B
Selecta Biosciences has gained $15.1 million in a Series B financing round. Existing investors Polaris Venture Partners and Flagship Ventures led the round, joined by NanoDimension and immunologist Read more...
Latest Headlines
- February 25, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
